Cheng Da Biotechnology Revenue and Competitors
Estimated Revenue & Valuation
- Cheng Da Biotechnology's estimated annual revenue is currently $3.6M per year.
- Cheng Da Biotechnology's estimated revenue per employee is $155,000
Employee Data
- Cheng Da Biotechnology has 23 Employees.
- Cheng Da Biotechnology grew their employee count by 10% last year.
Cheng Da Biotechnology's People
Name | Title | Email/Phone |
---|
Cheng Da Biotechnology Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Cheng Da Biotechnology?
Liaoning Chengda Biotechnology Co., Ltd. is a biotechnology company based out of Zhonggong North Street 40th Alley, Shenyang, Liaoning, China.
keywords:N/AN/A
Total Funding
23
Number of Employees
$3.6M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cheng Da Biotechnology News
2022-04-17 - L-Carnitine Market Worth US$ 262.6 Mn by 2027 by Focusing ...
LTD, Biosint S.p.A., Cayman Chemical, Cheng Da PharmaCeuticals Co., ... market has been segmented into chemical synthesis and bio-process.
2022-04-13 - Factors predicting serum clozapine levels in Middle Eastern patients ...
Bethesda: National Center for Biotechnology Information (US); 2016. ... Ruan CJ, Zang YN, Cheng YH, Wang CY, De Leon J. Around 3% of 1,300...
2022-03-22 - Compositions of gut microbiota before and shortly after hepatitis C ...
... committee at each site (Institutional Review Board of the E-Da Hospital, ... experts at the Germark Biotechnology (Taichung, Taiwan).
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $420.1M | 850 | 2% | N/A |